Masterclasses

Day A: Schizophrenia / Substance Misuse

Declarations of Interests

Professor Thomas Barnes

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. n the last three years, I have been a member of scientific advisory boards for Otsuka/Lundbeck, Newron Pharmaceuticals and Gedeon Richter.

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. I have received speaker fees from Janssen

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. No

Form completed on 27th February 2019

Dr Lesley Peters

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:

Form completed on 31st January 2017

Professor Anne Lingford-Hughes

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. Husband holds GSK shares

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. Silence; consulted by but received no monies from Britannia Pharmaceuticals, GLG, Opiant, Lightlake and Dobrin.

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. Janssen-Cilag, Lundbeck

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. No

Form completed on 6th June 2019

Professor Julia Sinclair

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. Lundbeck A/S for alcohol use disorder treatment. Merck for alcohol use disorder treatment

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:

Form completed on 14th November 2018

Dr Richard Drake

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. All money went to the University of Manchester, so no retainer to me

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. All money (from Sunovion, Otsuka) went to the University of Manchester

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. All monies went to the University of Manchester. Companies: Janssen, Otsuka

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. Have collaborated with EFPIA consortium on the NEWMEDS project: http://www.newmeds-europe.com/en/consortium.php

Form completed on 31st January 2017

Professor Mitul Mehta

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. Acted as an advisory Board Member for Lundbeck on one programme

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. Lundbeck (investigator initiated grant), Takeda (clinical trial)

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:

Form completed on 31st July 2019

Professor Alan Currie

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. Lundbeck Ltd, Janssen-Cilag Ltd

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. I have received payments from United Kingdom Anti-Doping (UKAD) for advising on policies and for adjudicating Therapeutic Use Exemption (TUE) applications.

Form completed on 11th December 2017